We present here a report on a 5-year experience in clinical investigat
ion, diagnostic management and molecular genetic studies of neuromitoc
hondrial disorders, defined on the basis of morphological, biochemical
and genetic findings. Leigh disease is the most frequent clinical pre
sentation in infancy and childhood, but symptoms al onset are poorly i
nformative. In paediatric cases, lactic acidosis and neuroradiological
abnormalities are frequent, and can be of help for the diagnostic ori
entation. In the adult population, muscle weakness, ophthalmoplegia wi
th ragged-red fibres, retinitis pigmentosa, progressive myoclonal atax
ia, and early-onset stroke-like episodes, are frequently combined in c
omplex syndromes that are often familial (maternally inherited) and/or
associated with well-established mutations in mitochondrial DNA (mtDN
A). However, the presence of overlap syndromes and features common to
many neuromitochondrial diseases can complicate the clinical evaluatio
n and the diagnostic approach, The pathogenicity of a given mtDNA muta
tion can frequently be ascertained by correlating the degree of hetero
plasmy with the clinical or biochemical phenotypes. Moreover, transmit
ochondrial cybrids can be used to test the effects of either mitochond
rial or nuclear gene abnormalities in a fully controlled, user-friendl
y and highly informative system.